Medexus Pharmaceuticals Stock Market Outlook
| MDP Stock | 2.74 0.07 2.49% |
About 61% of Medexus Pharmaceuticals' investor base is looking to short. The analysis of overall sentiment of trading Medexus Pharmaceuticals stock suggests that many investors are alarmed at this time. Medexus Pharmaceuticals' investing sentiment overview a quick insight into current market opportunities from investing in Medexus Pharmaceuticals. Many technical investors use Medexus Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Comfort Level 39
Alarmed
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Medexus Pharmaceuticals' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Medexus Pharmaceuticals.
News SentimentNeutral | Hype SentimentBearish | Insider SentimentWaiting |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Medexus Pharmaceuticals is 'Strong Sell'. The recommendation algorithm takes into account all of Medexus Pharmaceuticals' available fundamental, technical, and predictive indicators you will find on this site.
Execute Medexus Pharmaceuticals Advice
The Medexus recommendation should be used to complement the investment advice compiled from the current analysts' consensus on Medexus Pharmaceuticals. Macroaxis does not own or have any residual interests in Medexus Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Medexus Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Weak | Details | |
Volatility | Relatively risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Small | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
For the selected time horizon Medexus Pharmaceuticals has a Mean Deviation of 1.64, Semi Deviation of 1.9, Standard Deviation of 2.23, Variance of 4.96, Downside Variance of 4.38 and Semi Variance of 3.6We provide investment recommendation to complement the last-minute expert consensus on Medexus Pharmaceuticals. Our dynamic recommendation engine harnesses a multidimensional algorithm to analyze the entity's potential to grow using all technical and fundamental data available at the time. To make sure Medexus Pharmaceuticals is not overpriced, please verify all Medexus Pharmaceuticals fundamentals, including its net income, number of employees, and the relationship between the price to sales and cash flow from operations .
Medexus Pharmaceuticals Trading Alerts and Improvement Suggestions
| Latest headline from news.google.com: Medexus Pharmaceuticals Trading Up 2.1 percent - Whats Next - MarketBeat |
Medexus Pharmaceuticals Returns Distribution Density
The distribution of Medexus Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Medexus Pharmaceuticals' future price movements. The chart of the probability distribution of Medexus Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Medexus Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Medexus Pharmaceuticals returns is essential to provide solid investment analysis for Medexus Pharmaceuticals.
| Mean Return | 0.05 | Value At Risk | -3.6 | Potential Upside | 3.81 | Standard Deviation | 2.23 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Medexus Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Medexus Pharmaceuticals Cash Flow Accounts
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Change In Cash | (8.7M) | 3.1M | (7.8M) | 18.7M | 21.5M | 22.6M | |
| Free Cash Flow | (8.9M) | (1.8M) | 18.4M | 21.3M | 24.5M | 25.7M | |
| Capital Expenditures | 7.7M | 362K | 266K | 2.7M | 3.1M | 2.0M | |
| Net Income | (2.9M) | 1.2M | (214K) | 2.2M | 2.0M | 2.1M | |
| End Period Cash Flow | 10.0M | 13.1M | 5.3M | 24.0M | 27.6M | 28.9M | |
| Other Non Cash Items | (11.3M) | 11.6M | 9.2M | 9.2M | 10.5M | 11.1M | |
| Change To Inventory | (8.4M) | (2.0M) | (9.1M) | (4.6M) | (4.1M) | (3.9M) | |
| Depreciation | 6.1M | 6.1M | 5.8M | 7.2M | 8.3M | 8.7M | |
| Investments | (8.2M) | (1.7M) | (3.5M) | (6.0M) | (6.9M) | (7.2M) | |
| Net Borrowings | 3.7M | 10.7M | (26.4M) | (14.2M) | (12.8M) | (12.2M) | |
| Change To Netincome | 633K | 27.1M | (9.2M) | 6.5M | 7.5M | 4.9M |
Medexus Pharmaceuticals Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Medexus Pharmaceuticals or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Medexus Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Medexus stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.03 | |
β | Beta against Dow Jones | 0.16 | |
σ | Overall volatility | 2.31 | |
Ir | Information ratio | -0.01 |
Medexus Pharmaceuticals Volatility Alert
Medexus Pharmaceuticals currently demonstrates below-average downside deviation. It has Information Ratio of -0.01 and Jensen Alpha of 0.03. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Medexus Pharmaceuticals' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Medexus Pharmaceuticals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Medexus Pharmaceuticals Fundamentals Vs Peers
Comparing Medexus Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Medexus Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Medexus Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Medexus Pharmaceuticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Medexus Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Medexus Pharmaceuticals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Medexus Pharmaceuticals to competition |
| Fundamentals | Medexus Pharmaceuticals | Peer Average |
| Return On Equity | 0.009 | -0.31 |
| Return On Asset | 0.0254 | -0.14 |
| Profit Margin | 0 % | (1.27) % |
| Operating Margin | 0.07 % | (5.51) % |
| Current Valuation | 107.92 M | 16.62 B |
| Shares Outstanding | 32.42 M | 571.82 M |
| Shares Owned By Insiders | 7.21 % | 10.09 % |
| Shares Owned By Institutions | 3.35 % | 39.21 % |
| Number Of Shares Shorted | 102.71 K | 4.71 M |
| Price To Book | 1.29 X | 9.51 X |
| Price To Sales | 0.88 X | 11.42 X |
| Revenue | 108.33 M | 9.43 B |
| Gross Profit | 63.95 M | 27.38 B |
| EBITDA | 16.81 M | 3.9 B |
| Net Income | 2.25 M | 570.98 M |
| Cash And Equivalents | 23.97 M | 2.7 B |
| Total Debt | 37.18 M | 5.32 B |
| Book Value Per Share | 2.19 X | 1.93 K |
| Cash Flow From Operations | 24.03 M | 971.22 M |
| Short Ratio | 2.48 X | 4.00 X |
| Earnings Per Share | 0.01 X | 3.12 X |
| Target Price | 6.89 | |
| Number Of Employees | 91 | 18.84 K |
| Beta | 1.98 | -0.15 |
| Market Capitalization | 91.1 M | 19.03 B |
| Total Asset | 171.84 M | 29.47 B |
| Retained Earnings | (61.99 M) | 9.33 B |
| Working Capital | (16.74 M) | 1.48 B |
| Net Asset | 171.84 M |
Medexus Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Medexus . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 5924.23 | |||
| Daily Balance Of Power | (0.39) | |||
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 2.74 | |||
| Day Typical Price | 2.74 | |||
| Price Action Indicator | (0.04) | |||
| Period Momentum Indicator | (0.07) |
About Medexus Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell Medexus Pharmaceuticals? Buying financial instruments such as Medexus Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Medexus Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Military Industrial Thematic Idea Now
Military Industrial
A collection of large United States defense contractors including companies involved in production or distribution of aircraft, ships, vehicles, weaponry, and electronic systems in cooperation with the government. The Military Industrial theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Military Industrial Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Medexus Stock
Medexus Pharmaceuticals financial ratios help investors to determine whether Medexus Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medexus with respect to the benefits of owning Medexus Pharmaceuticals security.